Medicis Reports Fourth Quarter and Year-End 2009 Financial Results
25 févr. 2010 16h05 HE
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., Feb. 25, 2010 (GLOBE NEWSWIRE) --
Fourth Quarter 2009 Financial Highlights
Revenues, $179.0 million, increased approximately 31.7% versus previous year
Non-GAAP net...
Medicis Announces 2009 Fourth Quarter and Year-End Conference Call and Webcast
22 févr. 2010 08h00 HE
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., Feb. 22, 2010 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced it expects to report 2009 fourth quarter and year-end financial results after the market closes on Thursday,...
Photo Release -- Medicis Begins Shipping RESTYLANE-L(TM) and PERLANE-L(TM)
18 févr. 2010 09h00 HE
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., Feb. 18, 2010 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the Company has begun shipment of the dermal fillers RESTYLANE-L™ and PERLANE-L™. On...
Medicis Receives Approval for RESTYLANE(R) and PERLANE(R) With Lidocaine
03 févr. 2010 08h00 HE
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., Feb. 3, 2010 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the U.S. Food and Drug Administration (FDA) has approved the dermal fillers RESTYLANE®-L and...
Medicis to Present at J.P. Morgan Healthcare Conference
11 janv. 2010 08h00 HE
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., Jan. 11, 2010 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the Company is scheduled to present at the 28th Annual J.P. Morgan Healthcare Conference in San Francisco,...
Medicis to Present at Goldman Sachs Healthcare Conference
04 janv. 2010 08h00 HE
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., Jan. 4, 2010 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the Company is scheduled to present at the Goldman Sachs Healthcare CEOs Unscripted Conference in New York...
Medicis Declares Cash Dividend
16 déc. 2009 08h00 HE
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., Dec. 16, 2009 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that its Board of Directors declared a quarter-end cash dividend of $0.04 per issued and outstanding share of...
Medicis to Present at Piper Jaffray Annual Health Care Conference
24 nov. 2009 08h00 HE
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., Nov. 24, 2009 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the Company is scheduled to present at the Piper Jaffray 21st Annual Health Care Conference in New York...
Medicis to Present at Credit Suisse Annual Healthcare Conference
09 nov. 2009 08h00 HE
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., Nov. 9, 2009 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the Company is scheduled to present at the Credit Suisse Annual Healthcare Conference in Phoenix, Arizona. A...
Medicis Reports Third Quarter 2009 Financial Results
04 nov. 2009 16h05 HE
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., Nov. 4, 2009 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced revenues of approximately $151.8 million for the three months ended September 30, 2009, compared to revenues of...